3–29 Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial
✍ Scribed by Buchholz, T.A.
- Book ID
- 123548471
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 120 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1043-321X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: The british columbia randomized radiation trial was designed to determine the survival impact of locoregional radiation therapy in premenopausal patients with lymph node-positive breast cancer treated by modified radical mastectomy and adjuvant chemotherapy. three hundred eighteen pa
Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b